Cardiovascular Devices Market size to cross USD 152 billion by 2035

The global cardiovascular devices market was valued at USD 74 billion in 2025 and is projected to grow from USD 79 billion in 2026 to USD 152 billion by 2035, expanding at a CAGR of 7.5%, according to the latest report published by Global Market Insights Inc.

Increasing Number of Patients Suffering from Cardiovascular Diseases

The rising incidence of cardiovascular diseases worldwide has become a major driver of demand for advanced cardiac care solutions. Sedentary lifestyles, unhealthy dietary habits, rising obesity rates, diabetes prevalence, and increasing stress levels have significantly contributed to the growing burden of heart-related conditions such as coronary artery disease, heart failure, and arrhythmias.

Expanding Geriatric Population

The expanding geriatric population is significantly contributing to the growth of the cardiovascular care market, as older individuals are more susceptible to heart-related diseases and complications. Aging leads to natural wear and tear of the cardiovascular system, including reduced elasticity of blood vessels, weakened heart muscles, and increased risk of hypertension and other chronic conditions.

High Risk Associated with Cardiac Procedures

Cardiac procedures are often associated with high levels of clinical risk due to the complexity and critical nature of cardiovascular interventions. Surgeries such as angioplasty, bypass operations, and valve replacements require precision and carry potential complications, including infection, bleeding, stroke, and postoperative recovery challenges. The invasive nature of many cardiac treatments increases patient vulnerability, particularly among elderly individuals and those with multiple comorbidities.

Browse key industry insights spread across 140 pages with 225 market data tables and figures from the report, Cardiovascular Devices Market, “By – Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Other Applications), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Other End Users) – Growth Forecast.” in detail, along with the table of contents: https://www.gminsights.com/industry-analysis/cardiovascular-devices-market  

Rising Adoption of Therapeutic and Surgical Devices Segment

The therapeutic and surgical devices segment generated USD 60.4 billion in 2025. This segment comprised a wide range of essential cardiovascular solutions, including catheters, coronary intervention systems, cardiac rhythm management devices, structural heart implants, and surgical instruments used in cardiac procedures. These devices played a central role in restoring or replacing critical heart functions, making them indispensable in interventional cardiology and cardiac surgery. The segment maintained its leading position due to its ability to deliver immediate and life-saving treatment options for severe cardiovascular conditions.  

Rising Prevalence of Cardiac Arrhythmia

The cardiac arrhythmia segment led the cardiovascular devices market and recorded the highest revenue of USD 25.5 billion in 2025. This dominance was driven by the high global prevalence of abnormal heart rhythms and the increasing number of patients requiring continuous monitoring and therapeutic intervention. Conditions such as atrial fibrillation, tachycardia, and bradycardia became more widespread due to aging populations and the rising incidence of risk factors, including obesity, hypertension, and diabetes.

North America to Emerge as a Propelling Region

North America cardiovascular devices market accounted for 41.8% share in 2025, supported by the rising burden of cardiovascular diseases across the region. The increasing prevalence of conditions such as heart attacks, arrhythmias, and heart failure, driven by sedentary lifestyles, obesity, and hypertension, has strengthened demand for advanced cardiovascular care solutions.

Key companies operating in the cardiovascular devices industry include Abbott Laboratories, AngioDynamics, Biotronik, Boston Scientific, Johnson & Johnson MedTech, Philips, Medtronic, Meril Life Sciences, MicroPort Scientific, Olympus Corporation, Penumbra, Relisys Medical Devices, Sahajanand Medical Technologies, Terumo Corporation, and Translumina Therapeutics.

Companies in the cardiovascular devices market focused on continuous innovation in minimally invasive technologies, advanced stents, and next-generation cardiac rhythm management systems to improve treatment outcomes and procedural safety. Market players invested heavily in research and development to enhance device precision, durability, and patient compatibility. Strategic collaborations with hospitals, research institutes, and healthcare providers helped accelerate clinical adoption and expand product reach.

In December 2025, vTitan Corporation launched vCardio, a single-lead wearable point-of-care cardiac monitor and announced that the device was fully designed and manufactured in India. It also stated that it delivered an end-to-end healthcare solution integrating hardware with cloud-based AI analytics in the health tech sector.